therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin

Outcomes

01
acute-graft-versus-host-disease-grade-ii-iv-cumulative-incidence
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
02
acute-graft-versus-host-disease-grade-iii-iv-cumulative-incidence
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
03
chronic-graft-versus-host-disease-cumulative-incidence
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
04
hematology-time-to-neutrophil-engraftment-anc-500-per-microliter
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
05
hematology-time-to-platelet-engraftment-20k-per-microliter
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
06
oncology-relapse-cumulative-incidence
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
07
survival-graft-versus-host-disease-free-relapse-free-probability
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
08
survival-overall-probability
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
09
survival-progression-free-probability
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival
10
survival-treatment-related-mortality-cumulative-incidence
1 evidence row
- van-besien_2016_cohort_reduced-intensity-haplo-plus-single-cord-transplant-compared-to-double-cord-transplant-improved-engraftment-and-graft-versus-host-disease-free-relapse-free-survival

therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin

Outcomes

acute-graft-versus-host-disease-grade-ii-iv-cumulative-incidence

acute-graft-versus-host-disease-grade-iii-iv-cumulative-incidence

chronic-graft-versus-host-disease-cumulative-incidence

hematology-time-to-neutrophil-engraftment-anc-500-per-microliter

hematology-time-to-platelet-engraftment-20k-per-microliter

oncology-relapse-cumulative-incidence

survival-graft-versus-host-disease-free-relapse-free-probability

survival-overall-probability

survival-progression-free-probability

survival-treatment-related-mortality-cumulative-incidence